Journal of The Academy of Clinical Microbiologists

Register      Login

VOLUME 21 , ISSUE 1 ( January-June, 2019 ) > List of Articles

CASE REPORT

Phaeoacremonium parasiticum hand infection in renal transplant patient

Sheeja TM Rajan, Sindhu Bhaskaran, Mamta George, Sapna Helen George

Keywords : Immunosuppression, opportunistic infection, phaeoacremonium, phaeohyphomycosis, renal transplantation

Citation Information : Rajan ST, Bhaskaran S, George M, George SH. Phaeoacremonium parasiticum hand infection in renal transplant patient. 2019; 21 (1):40-43.

DOI: 10.4103/jacm.jacm_24_18

License: CC BY-NC 4.0

Published Online: 30-06-2019

Copyright Statement:  Copyright © 2019; Wolters Kluwer India Pvt. Ltd.


Abstract

Phaeohyphomycosis is a group of rare opportunistic infections caused by dematiaceous fungi. Their significance in the newly emerging and rare fungal infections of solid organ transplant recipients is being increasingly recognised. We present a case of fungal infection of both hands in a post-renal transplant patient on immunosuppressive drugs, by Phaeoacremonium parasiticum. Diagnostic confirmation by fungal cultures, histopathologic examination with special stains and confirmation by polymerase chain reaction technique was done. Remission was achieved by a combination of surgical debulking followed by systemic azoles, intralesional amphotericin B and saturated solution of potassium iodide. Significance of such infections in transplant tourism is implicated since the fungus is frequently found in tropical and subtropical regions.


PDF Share
  1. Ajello L, Georg LK, Steigbigel RT, Wang CJ. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia 1974;66:490-8.
  2. Mostert L, Halleen F, Fourie P, Crous PW. A review of Phaeoacremonium species involved in Petri disease and esca of grapevines. Phytopathol Mediterr 2006;45:12-29.
  3. Crous P, Gams W, Wingfield M, Van Wyk PS. Phaeoacremonium gen. Nov. Associated with wilt and decline diseases of woody hosts and human infections. Mycologia 1996;88:786-96.
  4. Kumar KK, Hallikeri K. Phaeohyphomycosis. Indian J Pathol Microbiol 2008;51:556-8.
  5. Sharma NL, Mahajan V, Sharma RC, Sharma A. Subcutaneous pheohyphomycosis in India – A case report and review. Int J Dermatol 2002;41:16-20.
  6. Mishra D, Singal M, Rodha MS, Subramanian A. Subcutaneous phaeohyphomycosis of foot in an immunocompetent host. J Lab Physicians 2011;3:122-4.
  7. Kubak BM, Huprikar SS; AST Infectious Diseases Community of Practice. Emerging & rare fungal infections in solid organ transplant recipients. Am J Transplant 2009;9 Suppl 4:S208-26.
  8. Revankar SG. Phaeohyphomycosis in transplant patients. J Fungi (Basel) 2015;2. pii: E2.
  9. Guégan S, Garcia-Hermoso D, Sitbon K, Ahmed S, Moguelet P, Dromer F, et al. Ten-year experience of cutaneous and/or subcutaneous infections due to coelomycetes in France. Open Forum Infect Dis 2016;3:ofw106.
  10. Cornely OA, Cuenca-Estrella M, Meis JF, Ullmann AJ. European Society of Clinical Microbiology and infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases. Clin Microbiol Infect 2014;20 Suppl 3:1-4.
  11. Ogawa MM, Galante NZ, Godoy P, Fischman-Gompertz O, Martelli F, Colombo AL, et al. Treatment of subcutaneous phaeohyphomycosis and prospective follow-up of 17 kidney transplant recipients. J Am Acad Dermatol 2009;61:977-85.
  12. Larsen CG, Arendrup MC, Krarup E, Pedersen M, Thybo S, Larsen FG. Subcutaneous phaeohyphomycosis in a renal transplant recipient successfully treated with voriconazole. Acta Derm Venereol 2009;89:657-8.
  13. Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M. In vitro activities of isavuconazole and comparator antifungal agents tested against a global collection of opportunistic yeasts and molds. J Clin Microbiol 2013;51:2608-16.
  14. Costa RO, Macedo PM, Carvalhal A, Bernardes-Engemann AR. Use of potassium iodide in dermatology: Updates on an old drug. An Bras Dermatol 2013;88:396-402.
  15. Narendranath S, Sudhakar GK, Pai MR, Kini H, Pinto J, Pai MR, et al. Safety and efficacy of oral potassium iodide in chromoblastomycosis. Int J Dermatol 2010;49:341-3.
  16. Gugnani HC, Ramesh V, Sood N, Guarro J, Moin-Ul-Haq, Paliwal-Joshi A, et al. Cutaneous phaeohyphomycosis caused by Caldosporium oxysporum and its treatment with potassium iodide. Med Mycol 2006;44:285-8.
  17. Marques SA, Camargo RM, Summerbell RC, De Hoog GS, Ishioka P, Chambô-Cordaro LM, et al. Subcutaneous phaeohyphomycosis caused by Phaeoacremonium parasiticum in a renal transplant patient. Med Mycol 2006;44:671-6.
  18. Mahajan VK, Sharma V, Prabha N, Thakur K, Sharma NL, Rudramurthy SM, et al. Arare case of subcutaneous phaeohyphomycosis caused by a Rhytidhysteron species: A clinico-therapeutic experience. Int J Dermatol 2014;53:1485-9.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.